BioSpace

Opinion: FDA must ensure American patients can access new and experimental drugs

The FDA has taken important steps through Operation TrialBlazer and stronger scrutiny of foreign clinical data, but more must be done to make the United States more competitive in attracting clinical trials as China’s capabilities rise.

Por BioSpace

1 minuto de lectura
Compartir
Opinion: FDA must ensure American patients can access new and experimental drugs
Opinion: FDA must ensure American patients can access new and experimental drugs

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Health Tech

Perspectivas relacionadas